Beyond Genomics of Waltham, Mass., and Novartis have announced a collaboration on cardiovascular disease research.
Novartis will provide patient plasma samples to Beyond Genomics, which will seek molecular markers for cardiovascular disease through bioinformatics analyses, Beyond Genomics said in a statement.
Financial terms were not disclosed.